Publication: Integrative epigenomics in Sjögren´s syndrome reveals novel pathways and a strong interaction between the HLA, autoantibodies and the interferon signature
dc.contributor.author | Teruel, María | |
dc.contributor.author | Barturen, Guillermo | |
dc.contributor.author | Martínez-Bueno, Manuel | |
dc.contributor.author | Castellini-Pérez, Olivia | |
dc.contributor.author | Barroso-Gil, Miguel | |
dc.contributor.author | Povedano, Elena | |
dc.contributor.author | Kerick, Martin | |
dc.contributor.author | Català-Moll, Francesc | |
dc.contributor.author | Makowska, Zuzanna | |
dc.contributor.author | Buttgereit, Anne | |
dc.contributor.author | Pers, Jacques-Olivier | |
dc.contributor.author | Marañón, Concepción | |
dc.contributor.author | Ballestar, Esteban | |
dc.contributor.author | Martin, Javier | |
dc.contributor.author | Carnero-Montoro, Elena | |
dc.contributor.author | Alarcón-Riquelme, Marta E. | |
dc.contributor.authoraffiliation | [Teruel,M; Barturen,G; Martínez-Bueno,M; Castellini-Pérez,O; Barroso-Gil,M; Povedano,E; Marañón,C; Carnero-Montoro,E; Alarcón-Riquelme,ME] GENYO, Center for Genomics and Oncological Research Pfizer/University of Granada/Andalusian Regional Government, Granada, Spain. [Kerick,M; Martin,J] IPBLN-CSIC, Instituto de Parasitología y Biomedicina López-Neyra, Consejo Superior de Investigaciones Científcas, Granada, Spain. [Català-Moll,F; Ballestar,E] Epigenetics and Immune Disease Group, Josep Carreras Research Institute (IJC), Badalona, Barcelona, Spain. [Català-Moll,F; Ballestar,E] IDIBELL, Bellvitge Biomedical Research Institute L’Hospitalet de Llobregat, Barcelona, Spain. [Makowska,Z; Buttgereit,A] Pharmaceuticals Division, Bayer Pharma Aktiengesellschaft, Berlin, Germany. [Pers,JO] Université de Brest, INSERM, Labex IGO, CHU de Brest, Brest, France.[Alarcón-Riquelme,ME] Institute for Environmental Medicine, Karolinska Institutet, Solna, Sweden. | |
dc.contributor.funder | Funding for the preparation of this manuscript has received support from the Innovative Medicines Initiative Joint Undertaking under grant agreement nº 115,565, resources composed of the financial contribution from the European Union's Seventh Framework Program (FP7/2007-2013) and the EFPIA companies’ in kind contribution. MT is supported by a Spanish grant from Health Department, Junta de Andalucía (PI/0017/2016) and through the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 806975. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA. EC-M was funded by the Postdoctoral Training Subprogramme Juan de la Cierva-Ministry of Economy and Competitiveness (FJCI_2014_20652). We thank Ralf Lesche for the production of RNASeq data and Marc Torres Ciuró for design support. | |
dc.contributor.group | PRECISESADS Clinical Consortium | es_ES |
dc.contributor.group | PRECISESADS Flow Cytometry Study Group | es_ES |
dc.date.accessioned | 2023-01-10T11:20:41Z | |
dc.date.available | 2023-01-10T11:20:41Z | |
dc.date.issued | 2021-12-02 | |
dc.description.abstract | Primary Sjögren’s syndrome (SS) is a systemic autoimmune disease characterized by lymphocytic infiltration and damage of exocrine salivary and lacrimal glands. The etiology of SS is complex with environmental triggers and genetic factors involved. By conducting an integrated multi-omics study, we confirmed a vast coordinated hypomethylation and overexpression effects in IFN-related genes, what is known as the IFN signature. Stratified and conditional analyses suggest a strong interaction between SS-associated HLA genetic variation and the presence of Anti-Ro/SSA autoantibodies in driving the IFN epigenetic signature and determining SS. We report a novel epigenetic signature characterized by increased DNA methylation levels in a large number of genes enriched in pathways such as collagen metabolism and extracellular matrix organization. We identified potential new genetic variants associated with SS that might mediate their risk by altering DNA methylation or gene expression patterns, as well as disease-interacting genetic variants that exhibit regulatory function only in the SS population. Our study sheds new light on the interaction between genetics, autoantibody profiles, DNA methylation and gene expression in SS, and contributes to elucidate the genetic architecture of gene regulation in an autoimmune population. | es_ES |
dc.description.version | Yes | es_ES |
dc.identifier.citation | Teruel M, Barturen G, Martínez-Bueno M, Castellini-Pérez O, Barroso-Gil M, Povedano E, Kerick M, et al. Integrative epigenomics in Sjögren´s syndrome reveals novel pathways and a strong interaction between the HLA, autoantibodies and the interferon signature. Sci Rep. 2021 Dec 2;11(1):23292 | es_ES |
dc.identifier.doi | 10.1038/s41598-021-01324-0 | es_ES |
dc.identifier.essn | 2045-2322 | |
dc.identifier.pmc | PMC8640069 | |
dc.identifier.pmid | 34857786 | es_ES |
dc.identifier.uri | http://hdl.handle.net/10668/4558 | |
dc.journal.title | Scientific Reports | |
dc.language.iso | en | |
dc.page.number | 18 p. | |
dc.publisher | Springer Nature | es_ES |
dc.relation.publisherversion | https://www.nature.com/articles/s41598-021-01324-0 | es_ES |
dc.rights | Atribución 4.0 Internacional | * |
dc.rights.accessRights | Acceso abierto | es_ES |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | * |
dc.subject | Autoantibodies | es_ES |
dc.subject | Epigenetic | es_ES |
dc.subject | Autoimmune diseases | es_ES |
dc.subject | Gene expression | es_ES |
dc.subject | Sjogren's syndrome | es_ES |
dc.subject | Genetic variation | es_ES |
dc.subject | Autoanticuerpos | es_ES |
dc.subject | Epigenómica | es_ES |
dc.subject | Enfermedades autoinmunes | es_ES |
dc.subject | Expresión génica | es_ES |
dc.subject | Síndrome de Sjögren | es_ES |
dc.subject | Variación genética | es_ES |
dc.subject.mesh | Medical Subject Headings::Phenomena and Processes::Chemical Phenomena::Biochemical Phenomena::Biochemical Processes::DNA Methylation | es_ES |
dc.subject.mesh | Medical Subject Headings::Check Tags::Female | es_ES |
dc.subject.mesh | Medical Subject Headings::Phenomena and Processes::Genetic Phenomena::Genetic Processes::Gene Expression | es_ES |
dc.subject.mesh | Medical Subject Headings::Phenomena and Processes::Genetic Phenomena::Genetic Processes::Gene Expression Regulation | es_ES |
dc.subject.mesh | Medical Subject Headings::Chemicals and Drugs::Biological Factors::Antigens::Antigens, Surface::Histocompatibility Antigens::HLA Antigens | es_ES |
dc.subject.mesh | Medical Subject Headings::Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans | es_ES |
dc.subject.mesh | Medical Subject Headings::Chemicals and Drugs::Amino Acids, Peptides, and Proteins::Peptides::Intercellular Signaling Peptides and Proteins::Interferons | es_ES |
dc.subject.mesh | Medical Subject Headings::Check Tags::Male | es_ES |
dc.subject.mesh | Medical Subject Headings::Diseases::Immune System Diseases::Autoimmune Diseases::Arthritis, Rheumatoid::Sjogren's Syndrome | es_ES |
dc.subject.mesh | Medical Subject Headings::Chemicals and Drugs::Amino Acids, Peptides, and Proteins::Proteins::Blood Proteins::Immunoproteins::Immunoglobulins::Antibodies | es_ES |
dc.subject.mesh | Medical Subject Headings::Disciplines and Occupations::Natural Science Disciplines::Biological Science Disciplines::Biology::Genetics::Genomics::Epigenomics | es_ES |
dc.subject.mesh | Medical Subject Headings::Phenomena and Processes::Genetic Phenomena::Genetic Variation | es_ES |
dc.subject.mesh | Medical Subject Headings::Phenomena and Processes::Genetic Phenomena::Genetic Processes::Gene Expression Regulation::Epigenesis, Genetic | es_ES |
dc.subject.mesh | Medical Subject Headings::Diseases::Immune System Diseases::Autoimmune Diseases | es_ES |
dc.title | Integrative epigenomics in Sjögren´s syndrome reveals novel pathways and a strong interaction between the HLA, autoantibodies and the interferon signature | es_ES |
dc.type | research article | |
dc.type.hasVersion | VoR | |
dspace.entity.type | Publication |
Files
Original bundle
1 - 5 of 24
Loading...
- Name:
- Teruel_IntegrativeEpigenomics.pdf
- Size:
- 3.81 MB
- Format:
- Adobe Portable Document Format
- Description:
- Artículo publicado
No Thumbnail Available
- Name:
- Teruel_IntegrativeEpigenomics_MaterialSuplementario_1.docx
- Size:
- 11.9 KB
- Format:
- Microsoft Word XML
- Description:
- Material suplementario
No Thumbnail Available
- Name:
- Teruel_IntegrativeEpigenomics_MaterialSuplementario_2.docx
- Size:
- 106.75 KB
- Format:
- Microsoft Word XML
- Description:
- Material suplementario
No Thumbnail Available
- Name:
- Teruel_IntegrativeEpigenomics_MaterialSuplementario_3.docx
- Size:
- 102.27 KB
- Format:
- Microsoft Word XML
- Description:
- Material suplementario
Loading...
- Name:
- Teruel_IntegrativeEpigenomics_MaterialSuplementario_4.pdf
- Size:
- 105.96 KB
- Format:
- Adobe Portable Document Format
- Description:
- Material suplementario
- 1 (current)
- 2
- 3
- 4
- 5